AAAAAA
Results: 1-25/43
Authors:
LOEHRER FMT
ANGST CP
BRUNNER FP
HAEFELI WE
FOWLER B
Citation: Fmt. Loehrer et al., EVIDENCE FOR DISTURBED S-ADENOSYLMETHIONINE-S-ADENOSYLHOMOCYSTEINE RATIO IN PATIENTS WITH END-STAGE RENAL-FAILURE - A CAUSE FOR DISTURBED METHYLATION REACTIONS, Nephrology, dialysis, transplantation, 13(3), 1998, pp. 656-661
Authors:
MULLERSCHWEINITZER E
STULZ P
STRIFFELER H
HAEFELI WE
Citation: E. Mullerschweinitzer et al., FUNCTIONAL-ACTIVITY AND TRANSMEMBRANE SIGNALING MECHANISMS AFTER CRYOPRESERVATION OF HUMAN INTERNAL MAMMARY ARTERIES, Journal of vascular surgery, 27(3), 1998, pp. 528-537
Authors:
SCHUERCH LV
LINDER LM
GROUZMANN E
HAEFELI WE
Citation: Lv. Schuerch et al., HUMAN NEUROPEPTIDE-Y POTENTIATES ALPHA-1-ADRENERGIC BLOOD-PRESSURE RESPONSES IN-VIVO, American journal of physiology. Heart and circulatory physiology, 44(3), 1998, pp. 760-766
Authors:
MULLERSCHWEINITZER E
SCHILLING M
HAEFELI WE
Citation: E. Mullerschweinitzer et al., FUNCTIONAL-ACTIVITY OF BRONCHI FROM AN ORGAN DONOR WITH FATAL ASTHMA - STUDIES ON CRYOPRESERVED BRONCHI, The Journal of asthma, 35(2), 1998, pp. 179-186
Authors:
KAUFMANN GR
VOZEH S
WENK M
HAEFELI WE
Citation: Gr. Kaufmann et al., SAFETY AND EFFICACY OF A 2-COMPARTMENT BAYESIAN FEEDBACK PROGRAM FOR THERAPEUTIC TOBRAMYCIN MONITORING IN THE DAILY CLINICAL USE AND COMPARISON WITH A NON-BAYESIAN ONE-COMPARTMENT MODEL, Therapeutic drug monitoring, 20(2), 1998, pp. 172-180
Authors:
SCHMASSMANNSUHIJAR D
BULLINGHAM R
GASSER R
SCHMUTZ J
HAEFELI WE
Citation: D. Schmassmannsuhijar et al., RHABDOMYOLYSIS DUE TO INTERACTION OF SIMVASTATIN WITH MIBEFRADIL, Lancet, 351(9120), 1998, pp. 1929-1930
Authors:
HUG B
KAESER YA
HAEFELI WE
BATTEGAY M
Citation: B. Hug et al., ANTIRETROVIRAL THERAPY AND ANTICONVULSANT DRUGS, Schweizerische medizinische Wochenschrift, 128(29-30), 1998, pp. 1138-1144
Authors:
SCHUERCH LV
NYFELER J
HOLDER G
SURBER C
HAEFELI WE
Citation: Lv. Schuerch et al., HAUNTING MEDICINES, American journal of health-system pharmacy, 54(20), 1997, pp. 2403-2403
Authors:
MULLERSCHWEINITZER E
MIHATSCH MJ
SCHILLING M
HAEFELI WE
Citation: E. Mullerschweinitzer et al., FUNCTIONAL RECOVERY OF HUMAN MESENTERIC AND CORONARY-ARTERIES AFTER CRYOPRESERVATION AT - 196-DEGREES-C IN A SERUM-FREE MEDIUM, Journal of vascular surgery, 25(4), 1997, pp. 743-750
Authors:
GASS A
FLAMMER J
LINDER L
ROMERIO SC
GASSER P
HAEFELI WE
Citation: A. Gass et al., INVERSE CORRELATION BETWEEN ENDOTHELIN-1-INDUCED PERIPHERAL MICROVASCULAR VASOCONSTRICTION AND BLOOD-PRESSURE IN GLAUCOMA PATIENTS, Graefe's archive for clinical and experimental ophthalmology, 235(10), 1997, pp. 634-638
Authors:
VISCHER UM
INGERSLEV J
WOLLHEIM CB
MESTRIES JC
TSAKIRIS DA
HAEFELI WE
KRUITHOF EKO
Citation: Um. Vischer et al., ACUTE VON-WILLEBRAND-FACTOR SECRETION FROM THE ENDOTHELIUM IN-VIVO - ASSESSMENT THROUGH PLASMA PROPEPTIDE (VWF-AGII) LEVELS, Thrombosis and haemostasis, 77(2), 1997, pp. 387-393
Authors:
JOANNIDES R
RICHARD V
HAEFELI WE
BENOIST A
LINDER L
LUSCHER TF
THUILLEZ C
Citation: R. Joannides et al., ROLE OF NITRIC-OXIDE IN THE REGULATION OF THE MECHANICAL-PROPERTIES OF PERIPHERAL CONDUIT ARTERIES IN HUMANS, Hypertension, 30(6), 1997, pp. 1465-1470
Authors:
HAEFELI WE
LINDER L
LUSCHER TF
Citation: We. Haefeli et al., QUINAPRILAT INDUCES ARTERIAL VASODILATION MEDIATED BY NITRIC-OXIDE INHUMANS, Hypertension, 30(4), 1997, pp. 912-917
Authors:
KNOLL B
HAEFELI WE
LADEWIG D
STOHLER R
Citation: B. Knoll et al., EARLY RECURRENCE OF WITHDRAWAL SYMPTOMS UNDER PHENYTOIN AND CHRONIC ALCOHOL-USE, Pharmacopsychiatry, 30(2), 1997, pp. 72-73
Authors:
TAMM M
SIEBER C
SCHNYDER F
HAEFELI WE
Citation: M. Tamm et al., MOXONIDINE-INDUCED CHOLESTATIC HEPATITIS, Lancet, 350(9094), 1997, pp. 1822-1822
Authors:
SCHILLER PI
MESSMER SL
HAEFELI WE
SCHLIENGER RG
BIRCHER AJ
Citation: Pi. Schiller et al., ANGIOTENSIN-CONVERTING ENZYME INHIBITOR-INDUCED ANGIOEDEMA - LATE-ONSET, IRREGULAR COURSE, AND POTENTIAL ROLE OF TRIGGERS, Allergy, 52(4), 1997, pp. 432-435
Authors:
LOEHRER FMT
SCHWAB R
ANGST CP
HAEFELI WE
FOWLER B
Citation: Fmt. Loehrer et al., INFLUENCE OF ORAL S-ADENOSYLMETHIONINE ON PLASMA 5-METHYLTETRAHYDROFOLATE, S-ADENOSYLHOMOCYSTEINE, HOMOCYSTEINE AND METHIONINE IN HEALTHY HUMANS, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 845-850
Authors:
LOEHRER FMT
ANGST CP
HAEFELI WE
JORDAN PP
RITZ R
FOWLER B
Citation: Fmt. Loehrer et al., LOW WHOLE-BLOOD S-ADENOSYLMETHIONINE AND CORRELATION BETWEEN 5-METHYLTETRAHYDROFOLATE AND HOMOCYSTEINE IN CORONARY-ARTERY DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 16(6), 1996, pp. 727-733
Authors:
SCHLIENGER RG
FLUSCHER TF
HAEFELI WE
Citation: Rg. Schlienger et al., CLINICAL PHARMACISTS EFFECT ON DRUG INFORMATION REQUESTS, The Annals of pharmacotherapy, 30(1), 1996, pp. 86-87
Authors:
LINDER L
LAUTENSCHLAGER BM
HAEFELI WE
Citation: L. Linder et al., SUBCONSTRICTOR DOSES OF NEUROPEPTIDE-Y POTENTIATE ALPHA(1)-ADRENERGICVENOCONSTRICTION IN-VIVO, Hypertension, 28(3), 1996, pp. 483-487
Authors:
SCHLIENGER RG
SAXER M
HAEFELI WE
Citation: Rg. Schlienger et al., REVERSIBLE AGEUSIA ASSOCIATED WITH LOSARTAN, Lancet, 347(8999), 1996, pp. 471-472
Authors:
STROBEL WM
LUSCHER TF
SIMPER D
LINDER L
HAEFELI WE
Citation: Wm. Strobel et al., SUBSTANCE-P IN HUMAN HAND VEINS IN-VIVO - TOLERANCE, EFFICACY, POTENCY, AND MECHANISM OF VENODILATOR ACTION, Clinical pharmacology and therapeutics, 60(4), 1996, pp. 435-443
Authors:
KAUFMANN GR
WENK M
TAESCHNER W
PETERLI B
GYR K
MEYER UA
HAEFELI WE
Citation: Gr. Kaufmann et al., N-ACETYLTRANSFERASE-2 POLYMORPHISM IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 62-67
Authors:
HAEFELI WE
OTT R
BIRCHER AJ
BURNENS AP
Citation: We. Haefeli et al., HAIR LOSS FOLLOWING TYPHOID-FEVER - A FORGOTTEN PHENOMENON, Clinical infectious diseases, 20(3), 1995, pp. 723-724
Authors:
TSAKIRIS DA
HAEFELI WE
LINDER L
STEINER B
MARBET GA
Citation: Da. Tsakiris et al., PLATELET SURFACE ACTIVATION MARKERS AFTER DDAVP INFUSION IN HEALTHY-SUBJECTS, Thrombosis and haemostasis, 74(3), 1995, pp. 991-992